Perrigo Company PLC Securities Class Litigation
BlackRock Global Allocation Fund, et al. v. Perrigo Company plc, et al., No. 2:20-cv-4748 (D.N.J.). Lieff Cabraser represented certain funds and accounts of BlackRock in a direct (non-class) action against Perrigo Company plc and former senior executives for violations of the Securities Exchange Act of 1934. Plaintiffs alleged defendants concealed from investors that (contrary to their public statements) Perrigo was engaged in a price-fixing scheme with respect to generic drugs, was impacted by pricing pressures in the generic pharmaceuticals industry, and had failed to successfully integrate Omega Pharma NV, Perrigo’s largest acquisition. After completion of fact and expert discovery, the case settled in 2025 on favorable confidential terms.
